CGON Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Neutral

59

7 8 12

Oscillators

Sell

35

4 5 1

Moving averages

Buy

74

3 3 11

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 7, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$6.28B

Growth and income

Eps-2.34

Free Cash Flow$-105.89M

Net Income$-60.2M

Profitability

Ebitda$-212.7M

Gross Profit$-1.88M

Balance sheet

Free Cash Flow$-105.89M

Total Assets$1.14B

Total Liabilities$43.48M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

ORKAORUKA THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement BCAXBICARA THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement FDMT4D MOLECULAR THERAPEUTICS IN+0.00%Market co-movement · Residual co-movement SYRESPYRE THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement NRIXNURIX THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

CG ONCOLOGY INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships